Tele: 561.316.3330
Breaking Medical Device News

Monday, October 18, 2021
HomeEXECUTIVESWilliam Sargent Appointed to a Senior VP Position with a Private Pharmaceutical...

William Sargent Appointed to a Senior VP Position with a Private Pharmaceutical Company

September 17, 2020

William Sargent has been appointed Senior Vice President of Venatorx Pharmaceuticals.

William Sargent has over 25 years of biopharmaceutical industry experience, including multiple products and line extension launches. He will be responsible for designing and executing Venatorx’s commercial strategy across its portfolio of clinical and preclinical antibacterial and antiviral programs.

“Will has a proven track record of success and extensive expertise across a wide array of therapeutic areas, most notably in antibiotics,” said Christopher J. Burns, Ph.D., President and CEO of Venatorx. “As we develop our domestic and global go-to-market strategies and competitive analyses for our clinical and preclinical programs, it’s vital to have expertise like Will’s to drive our unique positioning, business intelligence and commercial plans forward.”

Prior to joining Venatorx, Mr. Sargent served as Vice President, Commercial Strategy at Nabriva where he led the launch and commercialization for Xenleta, a novel antibiotic approved for the treatment of community acquired bacterial pneumonia (CABP). Previously, Mr. Sargent held a variety of leadership roles at Auxilium Pharmaceuticals, including Vice President, Orthopedic Business Unit where he led the company’s sales and marketing teams advancing XIAFLEX® for the treatment of Dupuytren’s contracture and development of additional pipeline indications. Before Auxilium, Mr. Sargent was a biotechnology equities analyst at Bank of America and held multiple commercial roles at Amgen and Immunex. Mr. Sargent received his BA in Biology from Johns Hopkins University and an MBA from the University of Washington Foster School of Business.

“As antibiotic resistance continues to reach dangerous levels in the U.S. and around the world, it is an exciting time to join a company that has become a driving force for innovation and transformation in the anti-infective space,” said Mr. Sargent. “Venatorx has a robust portfolio of clinical and preclinical antibacterial and antiviral assets that each have a unique value proposition and potential for long-term health benefits for patients. I’m thrilled to join this dynamic, dedicated team and look forward to leading the company’s strategic commercial plans to foster growth and partnership opportunities for the company and its assets.”

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy